Moreover, the expression of β-catenin is reduced in AD patients carrying PSEN1 mutations [13], and PSEN1 mutations associated with AD cause a perturbation in the intracellular trafficking of β-catenin [122], decrease the stability and/or enhance the degradation of β-catenin [123, 124]. This evidence concerns the gene PSEN1 and Alzheimer disease.